Catalyst Pharmaceutical Partners Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

2.61USD
12:33pm EST
Price Change (% chg)

$-0.05 (-1.88%)
Prev Close
$2.66
Open
$2.69
Day's High
$2.69
Day's Low
$2.60
Volume
32,622
Avg. Vol
340,844
52-wk High
$3.49
52-wk Low
$1.65

CPRX.OQ

Chart for CPRX.OQ

About

Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy. As of December 31, 2011,... (more)

Overall

Beta: 0.80
Market Cap (Mil.): $183.86
Shares Outstanding (Mil.): 69.12
Dividend: --
Yield (%): --

Financials

  CPRX.OQ Industry Sector
P/E (TTM): -- 269.72 39.20
EPS (TTM): -0.22 -- --
ROI: -40.78 -1.77 17.16
ROE: -45.53 -3.18 18.09
Search Stocks

UPDATE 1-Catalyst Pharma's lead drug succeeds in late-stage study

Sept 29 - Catalyst Pharmaceutical Partners Inc said its lead drug was found superior in treating symptoms associated with a rare autoimmune disorder, compared with a placebo.

29 Sep 2014

BRIEF-Catalyst Pharmaceuticals announces positive top-line PHASE 3 data from Firdapse clinical trial

* Announces positive top-line PHASE 3 data from Firdapse clinical trial in patients with lambert-eaton myasthenic syndrome

29 Sep 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks